Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank14
3Y CAGR-56.2%
5Y CAGR-28.4%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-56.2%/yr
vs +24.1%/yr prior
5Y CAGR
-28.4%/yr
Recent deceleration
Acceleration
-80.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$84.02M-32.4%
2024$124.29M-13.5%
2023$143.74M-85.6%
2022$998.92M+256.6%
2021$280.12M-37.4%
2020$447.65M+967.0%
2019$41.95M-90.0%
2018$421.50M-